
Opening bell ceremony at NASDAQ with participants from NASDAQ-TASE Biomed Investors Conference.
VP Business Development of BioLineRx, Nir Gamliel, is fourth on the right.
BioLineRx Appoints Tami Rachmilewitz, M.D., as Chief Medical Officer
BioLineRx to Participate in the 12th Annual LifeSci Partners Corporate Access Event